To investigate the function of ADAR2 in mesothelioma, we used CRISPR/Cas9 technology with three gRNAs to knockdown ADAR2 in the human Mero95 and mouse RN5 cell lines. This evidence concerns the gene ADARB1 and mesothelioma.